These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 27215532)
41. Loss of PCDH9 is associated with the differentiation of tumor cells and metastasis and predicts poor survival in gastric cancer. Chen Y; Xiang H; Zhang Y; Wang J; Yu G Clin Exp Metastasis; 2015 Jun; 32(5):417-28. PubMed ID: 25869928 [TBL] [Abstract][Full Text] [Related]
42. Increased expression of pleiotrophin is a prognostic marker for patients with gastric cancer. Hu H; Li C; Cai S; Zhu C; Tian Y; Zheng J; Hu J; Chen C; Liu W Hepatogastroenterology; 2014; 61(133):1478-82. PubMed ID: 25436328 [TBL] [Abstract][Full Text] [Related]
43. LAPTM4B-35, a cancer-related gene, is associated with poor prognosis in TNM stages I-III gastric cancer patients. Cheng X; Zheng Z; Bu Z; Wu X; Zhang L; Xing X; Wang X; Hu Y; Du H; Li L; Li S; Zhou R; Wen XZ; Ji JF PLoS One; 2015; 10(4):e0121559. PubMed ID: 25849595 [TBL] [Abstract][Full Text] [Related]
44. Pituitary tumor-transforming gene-1 serves as an independent prognostic biomarker for gastric cancer. Xu MD; Dong L; Qi P; Weng WW; Shen XH; Ni SJ; Huang D; Tan C; Sheng WQ; Zhou XY; Du X Gastric Cancer; 2016 Jan; 19(1):107-15. PubMed ID: 25627474 [TBL] [Abstract][Full Text] [Related]
45. Low expression of MAP1LC3B, associated with low Beclin-1, predicts lymph node metastasis and poor prognosis of gastric cancer. Yu S; Li G; Wang Z; Wang Z; Chen C; Cai S; He Y Tumour Biol; 2016 Nov; 37(11):15007-15017. PubMed ID: 27655288 [TBL] [Abstract][Full Text] [Related]
46. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer]. Wu F; Chen L; Wu W; Jiang B; Su X Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527 [TBL] [Abstract][Full Text] [Related]
47. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer. Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644 [TBL] [Abstract][Full Text] [Related]
48. [Expression tumor stem cell surface marker CD44 in gastric cancer and its significance]. Xie JW; Huang CM; Zheng CH; Li P; Wang JB; Lin JX; Lu J Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Nov; 16(11):1107-12. PubMed ID: 24277411 [TBL] [Abstract][Full Text] [Related]
49. [Effect of lymphatic vascular invasion on the prognosis of stage I( gastric cancer patients after radical gastrectomy]. Shang L; Li B; He F; Li Y; Li J; Zhao Q; Li M Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):175-179. PubMed ID: 29492916 [TBL] [Abstract][Full Text] [Related]
50. Prognostic value of decreased expression of RBM4 in human gastric cancer. Yong H; Zhu H; Zhang S; Zhao W; Wang W; Chen C; Ding G; Zhu L; Zhu Z; Liu H; Zhang Y; Wen J; Kang X; Zhu J; Feng Z; Liu B Sci Rep; 2016 Jun; 6():28222. PubMed ID: 27324405 [TBL] [Abstract][Full Text] [Related]
51. Identification and validation of Kallikrein-ralated peptidase 11 as a novel prognostic marker of gastric cancer based on immunohistochemistry. Wen YG; Wang Q; Zhou CZ; Yan DW; Qiu GQ; Yang C; Tang HM; Peng ZH J Surg Oncol; 2011 Oct; 104(5):516-24. PubMed ID: 21618246 [TBL] [Abstract][Full Text] [Related]
52. [Discovery and verification of matrix gla protein, a TNM staging and prognosis-related biomarker for gastric cancer]. Guo L; Guo XB; Jiang JL; Zhang JN; Ji J; Liu BY; Zhu ZG; Yu YY Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):436-41. PubMed ID: 21055170 [TBL] [Abstract][Full Text] [Related]
53. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer]. Song S; Liu H; Xue Y Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917 [TBL] [Abstract][Full Text] [Related]
54. Reduced expression of Rap1GAP as a prognostic biomarker for primary gastric cancer patients. Zhao J; Mai C; Weng D; Chen C; Zhou Z; Liu Y; Zhou Z; Wang P Cancer Biomark; 2018; 22(3):375-384. PubMed ID: 29758923 [TBL] [Abstract][Full Text] [Related]
55. The Intestinal Stem Cell Marker SMOC2 Is an Independent Prognostic Marker Associated With Better Survival in Gastric Cancer. Hyun CL; Park SJ; Kim HS; Song HJ; Kim HU; Lee C; Lee DH; Maeng YH; Kim YS; Jang B Anticancer Res; 2021 Jul; 41(7):3689-3698. PubMed ID: 34230168 [TBL] [Abstract][Full Text] [Related]
56. Expression of SIP1 is strongly correlated with LDHA and shows a significantly poor outcome in gastric cancer. Sun X; Sun Z; Zhu Z; Li C; Zhang J; Xu H; Sun M Tumour Biol; 2015 Sep; 36(10):7521-30. PubMed ID: 25913622 [TBL] [Abstract][Full Text] [Related]
57. [Analysis of clinicopathological characteristics and prognosis on 42 patients with primary gastric adenosquamous cell carcinoma]. Li B; Sun L; Wang X; Deng J; Ding X; Wang X; Ke B; Zhang L; Zhang R; Liang H Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):207-212. PubMed ID: 28226357 [TBL] [Abstract][Full Text] [Related]
58. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer. Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748 [TBL] [Abstract][Full Text] [Related]
59. [Surgical treatment and prognosis of Borrmann type IIII( gastric cancer involving the whole stomach]. Dong R; Zhang Z; Zhou Y; Hua Y; Guo J Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):185-189. PubMed ID: 29492918 [TBL] [Abstract][Full Text] [Related]
60. [Expressions of Sry-related High Mobility Group Box 9 and Gastrokine-1 in Gastric Cancer and Their Relationships with Prognosis]. Chen JB; Xu GS; Cai XJ; Liu HT; Sun KL; Luo X Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Jun; 41(3):315-322. PubMed ID: 31282324 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]